LLY vs NVST
Eli Lilly and Company vs Envista Holdings — AI-powered side-by-side comparison
LLY
Eli Lilly and Company
68
Buy
VS
NVST
Envista Holdings
70
Buy
| Metric | LLY | NVST |
|---|
| AI Score |
68
|
70
|
| Price |
$1,180.33
|
$28.07
|
| P/E Ratio |
39.54×
|
47.58×
|
| ROE |
77.8%
|
1.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
84.0%
|
55.5%
|
| Debt / Equity |
1.62×
|
0.52×
|
| Dividend Yield |
0.6%
|
0.0%
|
| RSI (14) |
57.1
|
53.5
|
| Beta |
0.506
|
0.861
|
| Expected Upside |
+5.8%
|
+1.9%
|
AI Committee View
Current Innellis committee reasoning for LLY versus NVST.
NVST leads by 2 points.
NVST scores 70/100 (Buy) versus LLY at 68/100 (Buy).
LLY Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
NVST Committee View
83% agreement
6 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is p/e of 47.3 is expensive by classic value standards. The committee is constructive but not yet at full conviction.
Bull Case
- Price-to-book of 1.1x is a discount to asset value — Value
- EPS growing 83.6% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
Bear Case
- P/E of 47.3 is expensive by classic value standards — Value
- ROE of only 3.1% -- cheap may mean cheap for a reason — Value